-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/measuring-blood-pressure-surveillance-160412.pdf
May 29, 2025 - "Sleep'time"
blood"pressure"as"a"therapeutic"target"for"cardiovascular"risk"reduction"in"type"2"diabetes … Sleep'time"ambulatory"blood"pressure"as"a"novel"therapeutic"target"for"
cardiovascular"risk"reduction … Home"blood"pressure"and"cardiovascular"outcomes"in"patients"during"
antihypertensive"therapy:"primary"results"of"HONEST … Efficacy"
and"safety"of"aliskiren"and"amlodipine"combination"therapy"in"patients"with"hypertension:" … received$home$BP$telemonitors$and$transmitted$BP$data$to$pharmacists$who$adjusted$
antihypertensive$therapy
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/stroke-atrial-fibrillation_executive.pdf
August 01, 2013 - Effectiveness Reviews,
the program supports systematic
appraisals of existing scientific
evidence regarding treatments … Research for CER 119,
“Treatment of Atrial Fibrillation,” focusing on the
treatment of AF through rate … There are also many novel invasive treatments for AF. … , and strategies for determining longer term
therapy given successful AF treatment … continued anticoagulant therapy
versus bridging therapies versus interruption of therapy
(i.e., stopping
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/medicare-medication-use_research.pdf
April 01, 2014 - Medicare beneficiaries with both medical
and psychiatric conditions likely experi-
ences complexity in treatment … The Medicare drug benefit (Part D) and
treatment of heart failure in older adults. … Effects of Medicare Part D coverage gap on
medication and medical treatment among elderly beneficiaries … Partnerships/downloads/11522-P.pdf
Data Points • #19 • Medication Use in Medicare
14
Appendix A: Part D therapeutic … Antiparkinson agents
Central nervous system agents Antianxiety agents Neuromuscular drugs Musculoskeletal therapy
-
effectivehealthcare.ahrq.gov/sites/default/files/dementia-horizon-scan-high-impact-1312.pdf
December 01, 2013 - , screening and diagnostics, therapeutics, surgery, programs, and
care delivery innovations that address … this intervention for treating AD and amnestic MCI.10 Various insulin products already
approved for diabetes … Experts commenting on this intervention agreed that the need for disease-modifying treatments
for AD … adoption: Experts anticipated that the drug’s well-known safety profile and
long history of use (in diabetes … Insulin: compare common
options for insulin therapy. [internet].
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-tests-applicability_methods.pdf
July 01, 2012 - Rapidly Evolving Tests
A third challenge, especially relevant to medical tests, is that, even more than treatments … Time from results to
treatment not
reported. … Both conditions are associated with risk of type II diabetes. … Treatment Trends
As therapeutics arise that change the course of disease and modify outcomes, literature … ., people with arthritis, women, obese
patients) or setting (e.g., primary care practice, physical therapy
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/antipsychotics-children_research-protocol.pdf
June 04, 2010 - gain, elevated lipids and prolactin levels, and have been associated with
the development of type 2 diabetes … adverse events include:
• Mortality
• Cerebrovascular disease-related events
• Development of diabetes … • Major adverse events: mortality, cerebrovascular disease-related events, development
of diabetes … age, sex, race,
weight, height, body mass index, co-morbidities, use of concurrent standard medical therapies … Phenothiazines/ad, to, tu, ct, po, ae [Administration & Dosage,
Toxicity, Therapeutic Use, Contraindications
-
effectivehealthcare.ahrq.gov/sites/default/files/ch_5-user-guide-to-ocer_130129.pdf
January 01, 2012 - Alternative Treatments
Comparison of a treatment with a clinically
meaningful alternative treatment … and glitazones for diabetes, and are
not commonly used off-label for other conditions,
the indication … analysis and external
adjustment for unmeasured confounders in
epidemiologic database studies of therapeutics … Hormone
replacement therapy and cardiovascular health in
the United States. Med Care. … Cancer risk in patients with rheumatoid
arthritis treated with anti–tumor necrosis factor
a therapies
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/women-hiv_research-protocol.pdf
March 01, 2016 - The comorbid conditions of interest
include cardiovascular disease, hypertension, type-2 diabetes, obesity … onset and progression of chronic diseases of
aging, including cardiovascular disease, hypertension, diabetes … treatments, is also not well elucidated. … For assessing the effectiveness and safety of treatments for co-occurring diseases or risk
factors, … Treatment of substance misuse in older women: using a
brief intervention model.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/psoriasis-chronic_research-protocol.pdf
January 10, 2012 - While biologic treatments may represent a treatment option with fewer adverse effects, there are
concerns … plaque psoriasis who are candidates
for systemic therapy or phototherapy when other therapies are … TNF-α Treatment of severe chronic plaque psoriasis in adults who are candidates for systemic
therapy … failed to respond to at least one systemic therapy or in patients for whom other
systemic therapies … and treatment of meningeal
leukemia; used alone or in combination therapy in the treatment of breast
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/medication-therapy-management_executive.pdf
November 01, 2014 - object is to help
consumers, health care providers, and
others in making informed choices
among treatment … Effectiveness Reviews,
the program supports systematic
appraisals of existing scientific
evidence regarding treatments … patient (i.e., a systematic process of collecting patient-specific information,
assessing medication therapies … substitution
issue; complex regimen that can be simplified with same therapeutic benefit; and potential … for
hypertension
and
dyslipidemia
Insufficient
for treatment
of patients
with diabetes,
depression
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/osteoarthritis-knee-update_research-protocol.pdf
June 15, 2016 - (including self-initiated therapies), and treatment
duration or intensity? … (including self-initiated therapies),
and treatment duration or intensity? … o Physical treatments and/or weight loss
§ Physical therapy and exercise programs
• Manual therapy … Stem cell therapy trials will not have high applicability as this
treatment is currently limited in … Diagnostic and
Therapeutic Criteria Committee of the
American Rheumatism Association.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/autoimmune-disease-rapid-research.pdf
November 01, 2024 - A class of
therapeutic agents called DMARDs (disease-modifying anti-rheumatic drugs) has been in use … or even a mix of both
therapy types. … Most of the included studies had
patients who were on either therapy or even a mix of both therapy types … .78 The reductions in PASI scores at 3-6
months post-NSPT may be considered half as effective as a therapeutic … Set# Searched for # Results
S21 S20 NOT (TI,AB(cancer* OR neoplasm* OR malignan* OR tumo$r* OR diabetes
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/outcomes-testing-evaluation_research.pdf
January 01, 2009 - may extend into the longer term.11 A randomized trial of
blood glucose self-monitoring among type 2 diabetes … perceptions or illness cognitions have been shown to affect adherence behavior
among patients with HIV, diabetes … Clinicians use tests to increase their diagnostic and therapeutic confidence. … Efficacy of self monitoring of blood
glucose in patients with newly diagnosed
type 2 diabetes (ESMON … How do
patients’ treatment preferences compare
with those of clinicians?
-
effectivehealthcare.ahrq.gov/sites/default/files/whitepaper4-bossuyt02262010-2.pdf
January 01, 2009 - may extend into the longer term.11 A randomized trial of
blood glucose self-monitoring among type 2 diabetes … perceptions or illness cognitions have been shown to affect adherence behavior
among patients with HIV, diabetes … Clinicians use tests to increase their diagnostic and therapeutic confidence. … Efficacy of self monitoring of blood
glucose in patients with newly diagnosed
type 2 diabetes (ESMON … How do
patients’ treatment preferences compare
with those of clinicians?
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/pressure-ulcer-prevention_research-protocol.pdf
January 10, 2012 - By one estimate,
treatment costs may be as much as 2.5 times the cost of prevention.
1
A number of … impairment; body weight;
nutritional status; incontinence; or specific medical comorbidities, such as diabetes … age, race or skin tone, physical impairment, body weight, or specific medical comorbidities (e.g., diabetes … www.effectivehealthcare.ahrq.gov
Published Online: January 10, 2012
6
comorbidities (e.g., diabetes … Waterlow pressure ulcer prevention/treatment policy card. Revised 2005.
-
effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/registry-of-patient-registries_research-2014.pdf
January 01, 2014 - purposes for patient registries
include evaluating the safety, effectiveness, or quality of medical treatments … Examples of outcome measures
Title Definition Type
Response to rituximab
treatment
Reduction of … For example, an important
outcome measure in diabetes care is management of HbA1c. … Members 18 - 75
years of ages
with diabetes. … Patient French
AutoImmunity
and Rituximab
(AIR) Registry
Response to rituximab
treatment, as measured
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/insomnia_research-protocol.pdf
April 03, 2014 - Treatment options are not limited to psychological and behavioral therapies and
pharmacologic interventions … Aroma therapy
Bright-light therapy
Brief behavioral therapy
Biofeedback
Cognitive behavioral therapy … cognitive behavioral therapy and drug therapy) for the treatment of insomnia
disorder in adults? … What are the harms of combined treatments (e.g. cognitive behavioral therapy
and drug therapy) for insomnia … Cognitive Behavioral Therapy for
Insomnia in Older Adults: Background,
Evidence, and Overview of Treatment
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/insomnia_protocol-140716.pdf
April 03, 2014 - Treatment options are not limited to psychological and behavioral therapies and
pharmacologic interventions … Aroma therapy
Bright-light therapy
Brief behavioral therapy
Biofeedback
Cognitive behavioral therapy … cognitive behavioral therapy and drug therapy) for the treatment of insomnia
disorder in adults? … What are the harms of combined treatments (e.g. cognitive behavioral therapy
and drug therapy) for insomnia … Cognitive Behavioral Therapy for
Insomnia in Older Adults: Background,
Evidence, and Overview of Treatment
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/high-cholestorol-medicines-update_disposition-comments.pdf
September 01, 2014 - baseline target from which to
go forward and randomize treatments. … What about harms associated with intensive
statin therapy such as diabetes or
rhabdomyolysis
What … For example, intensive statin therapy has been associated with an increased
risk of diabetes compared … Risk of incident diabetes with intensive-dose compared with
moderate-dose statin therapy: a meta-analysis.JAMA … In addition to therapeutic lifestyle changes, a
moderate or high dose of a statin therapy
should be
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/antipsychotic-medicine-cardiovascular-elderly_research.pdf
February 01, 2009 - Diabetes was defined by the presence of diagnoses plus use of
anti-diabetic medications. … Discussion
In this study of over 20,000 elderly patients initiating APM treatments, use of
conventional … Clin Therapeutics
2002;24(9):1466-76.
5. Chan YC, Pariser SF, Neufeld G. … arrhythmia 1.4 1.4
Cerebrovascular disease 29.1 30.9
CHF 32.6 31.1
Diabetes … *Controlled for calendar year, age, gender, race, prior arrhythmias, cerebrovascular disease, CHF, diabetes